Free Trial
ETR:SHL

Siemens Healthineers (SHL) Stock Price, News & Analysis

Siemens Healthineers logo
€52.10 -0.38 (-0.72%)
(As of 12/20/2024 ET)

About Siemens Healthineers Stock (ETR:SHL)

Key Stats

Today's Range
€51.66
€52.20
50-Day Range
€47.93
€54.10
52-Week Range
€45.51
€58.14
Volume
514,177 shs
Average Volume
N/A
Market Capitalization
$58.35 billion
P/E Ratio
31.39
Dividend Yield
1.82%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Receive SHL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Siemens Healthineers and its competitors with MarketBeat's FREE daily newsletter.

SHL Stock News Headlines

Siemens Healthineers (ETR:SHL) Trading 2.2% Higher - Time to Buy?
Has Trump Finally Gone Too Far?
Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.
See More Headlines

SHL Stock Analysis - Frequently Asked Questions

Siemens Healthineers' stock was trading at €52.60 at the beginning of the year. Since then, SHL shares have decreased by 1.0% and is now trading at €52.10.
View the best growth stocks for 2024 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Siemens Healthineers investors own include QUALCOMM (QCOM), Applied Materials (AMAT), Boeing (BA), Bristol-Myers Squibb (BMY), Netflix (NFLX), NVIDIA (NVDA) and Adobe (ADBE).

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
71,800
Year Founded
N/A

Profitability

Net Income
$1.86 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$22.09 billion
Cash Flow
€1.34 per share
Book Value
€16.33 per share

Miscellaneous

Outstanding Shares
1,120,000,000
Free Float
N/A
Market Cap
$58.35 billion
Optionable
Not Optionable
Beta
0.70
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

This page (ETR:SHL) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners